SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-000190
Filing Date
2022-01-10
Accepted
2022-01-10 17:12:18
Documents
74
Period of Report
2021-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q cydy-20211130x10q.htm   iXBRL 10-Q 2627868
2 EX-3.1 cydy-20211130xex3d1.htm EX-3.1 245928
3 EX-31.1 cydy-20211130xex31d1.htm EX-31.1 9515
4 EX-31.2 cydy-20211130xex31d2.htm EX-31.2 9437
5 EX-32.1 cydy-20211130xex32d1.htm EX-32.1 5496
6 EX-32.2 cydy-20211130xex32d2.htm EX-32.2 5474
7 GRAPHIC cydy-20211130xex3d1001.jpg GRAPHIC 2690
  Complete submission text file 0001558370-22-000190.txt   10517558

Data Files

Seq Description Document Type Size
8 EX-101.SCH cydy-20211130.xsd EX-101.SCH 64095
9 EX-101.CAL cydy-20211130_cal.xml EX-101.CAL 58667
10 EX-101.DEF cydy-20211130_def.xml EX-101.DEF 265969
11 EX-101.LAB cydy-20211130_lab.xml EX-101.LAB 428046
12 EX-101.PRE cydy-20211130_pre.xml EX-101.PRE 422045
68 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20211130x10q_htm.xml XML 2062343
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 22521970
SIC: 2834 Pharmaceutical Preparations